Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia

NCT02445352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

379

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: Rosuvastatin 5mg
DRUG: DP-R207 5/10mg
DRUG: Rosuvastatin 10mg
DRUG: DP-R207 10/10mg
DRUG: Rosuvastatin 20mg
DRUG: DP-R207 20/10mg
DRUG: Placebo (for Rosuvastatin 5mg and DP-R207 5/10mg)
DRUG: Placebo (for Rosuvastatin 10mg and DP-R207 10/10mg)
DRUG: Placebo (for Rosuvastatin 20mg and DP-R207 20/10mg)

Sponsor

Alvogen Korea